N-acetylglucosamine-6-sulfatase: Difference between revisions
CSV import |
CSV import |
||
| Line 24: | Line 24: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 19:34, 17 March 2025
N-acetylglucosamine-6-sulfatase (G6S) is an enzyme that is involved in the degradation of glycosaminoglycans in the body. This enzyme is encoded by the G6S gene in humans.
Function[edit]
N-acetylglucosamine-6-sulfatase is a lysosomal enzyme that catalyzes the removal of 6-sulfate groups from the N-acetyl-D-glucosamine 6-sulfate units of keratan sulfate and chondroitin sulfate. The enzyme is a member of the sulfatase family, which is a group of enzymes that catalyze the hydrolysis of sulfuric acid esters.
Clinical significance[edit]
Deficiency of N-acetylglucosamine-6-sulfatase leads to the lysosomal storage disorder Mucopolysaccharidosis type IIID (MPS IIID), also known as Sanfilippo syndrome type D. This is a rare and severe neurodegenerative disorder characterized by progressive mental and motor deterioration, leading to severe disability and death in early adulthood.
Structure[edit]
The G6S gene is located on the long arm of chromosome 12 (12q14) and spans approximately 40 kilobases. The gene encodes a protein of 552 amino acids with a calculated molecular mass of 63 kDa.
See also[edit]
References[edit]
<references />
